World's Best Scientists 2026 revealed!
Rhett P. Ketterling

Rhett P. Ketterling

D-Index & Metrics

Medicine

D-Index
94
Citations
34075
World Ranking
10448
National Ranking
5378

Overview

Rhett P. Ketterling is affiliated with the Mayo Clinic in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a considerable focus on Hematology, Molecular Biology, Genetics, Pathology and Forensic Medicine, and Public Health, Environmental and Occupational Health.

The scientist's work addresses major topics such as Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Acute Lymphoblastic Leukemia Research, Lymphoma Diagnosis and Treatment, Myeloproliferative Neoplasms: Diagnosis and Treatment, Multiple Myeloma Research and Treatments, and Chronic Lymphocytic Leukemia Research.

They have published extensively in venues like Blood Cancer Journal, Blood, American Journal of Hematology, Cancer Genetics, and Genes Chromosomes and Cancer. Notable recent papers include:

  • Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera, 2020, British Journal of Haematology
  • Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL, 2021, Blood
  • Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response, 2020, Blood Cancer Journal
  • Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities, 2020, Blood Advances
  • A simple additive staging system for newly diagnosed multiple myeloma, 2022, Blood Cancer Journal

Frequent co-authors collaborating with Rhett P. Ketterling include Patricia T. Greipp, Linda B. Baughn, Jess F. Peterson, Ayalew Tefferi, and Naseema Gangat. Their collaborative efforts contribute to research output in the aforementioned fields and topics.

Best Publications

  • Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

    Jay P. Patel;Mithat Gönen;Maria E. Figueroa;Hugo Fernandez

  • Anthracycline Dose Intensification in Acute Myeloid Leukemia

    Hugo F. Fernandez;Zhuoxin Sun;Xiaopan Yao;Mark R. Litzow

  • Long-term survival and blast transformation in molecularly-annotated essential thrombocythemia, polycythemia vera and myelofibrosis

    Ayalew Tefferi;Paola Guglielmelli;Dirk R. Larson;Christy Finke

  • CALR vs JAK2 vs MPL -mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

    A Tefferi;T L Lasho;C M Finke;R A Knudson

  • Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases

    Ruben A. Mesa;Chin Yang Li;Rhett P. Ketterling;Georgene S. Schroeder

  • MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.

    Paola Guglielmelli;Terra L. Lasho;Giada Rotunno;Mythri Mudireddy

  • ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

    Edgardo R. Parrilla Castellar;Elaine S. Jaffe;Jonathan W. Said;Steven H. Swerdlow

  • Microduplication 22q11.2, an Emerging Syndrome: Clinical, Cytogenetic, and Molecular Analysis of Thirteen Patients

    Regina E. Ensenauer;Adewale Adeyinka;Heather C. Flynn;Virginia V. Michels

  • Factor VIII gene inversions in severe hemophilia A: results of an international consortium study

    S. E. Antonarakis;J. P. Rossiter;M. Young;J. Horst

  • Genetic aberrations and survival in plasma cell leukemia.

    R E Tiedemann;N Gonzalez-Paz;R A Kyle;R Santana-Davila

  • CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy

    Animesh Pardanani;Animesh Pardanani;Animesh Pardanani;Rhett P. Ketterling;Rhett P. Ketterling;Rhett P. Ketterling;Stephanie R. Brockman;Stephanie R. Brockman;Stephanie R. Brockman;Heather C. Flynn;Heather C. Flynn;Heather C. Flynn

  • T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993).

    David I. Marks;Elisabeth M. Paietta;Anthony V. Moorman;Susan M. Richards

  • FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia.

    Animesh Pardanani;Stephanie R. Brockman;Sarah F. Paternoster;Heather C. Flynn

  • The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.

    Paola Guglielmelli;Terra L. Lasho;Giada Rotunno;Joannah Score

  • MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis

    Ayalew Tefferi;Paola Guglielmelli;Terra L. Lasho;Naseema Gangat

  • Targeted deep sequencing in polycythemia vera and essential thrombocythemia

    Ayalew Tefferi;Terra L. Lasho;Paola Guglielmelli;Christy M. Finke

  • CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients

    A Tefferi;P Guglielmelli;T L Lasho;G Rotunno

  • Prolonged Administration of Azacitidine With or Without Entinostat for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905

    Thomas Prebet;Zhuoxin Sun;Maria E. Figueroa;Rhett Ketterling

  • Lenalidomide therapy in myelofibrosis with myeloid metaplasia.

    Ayalew Tefferi;Jorge E Cortes;Jorge E Cortes;Jorge E Cortes;Srdan Verstovsek;Srdan Verstovsek;Srdan Verstovsek;Ruben A. Mesa;Ruben A. Mesa;Ruben A. Mesa

  • Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics.

    Shaji Kumar;Rafael Fonseca;Rhett P. Ketterling;Angela Dispenzieri

Frequent Co-Authors

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA doesn’t have to mean following a traditional path. Many students start or advance their healthcare careers through flexible online programs in nursing and related fields. These degrees offer cost savings, work-life balance, and access for learners who may not be able to attend on-campus classes.

For those looking to become advanced care providers, most affordable online nurse practitioner programs can prepare you for highly rewarding practitioner roles. If you’re just starting out, enrolling in an online nursing school can open the door to a range of entry-level nursing positions.

Ambitious nurses interested in higher education and research may consider phd in nursing online programs to reach the pinnacle of their field. Meanwhile, registered nurses can further their careers with the cheapest online bsn programs, which can unlock opportunities for leadership and specialized care.

These accredited online options empower motivated individuals to follow diverse career paths in medicine and healthcare while managing time and budget constraints.

Best Scientists Citing Rhett P. Ketterling

Trending Scientists

Recently Published Articles